Fairmount Healthcare Fund L.p. - Net Worth and Insider Trading

Fairmount Healthcare Fund L.p. Net Worth

The estimated net worth of Fairmount Healthcare Fund L.p. is at least $167 Million dollars as of 2024-11-05. Fairmount Healthcare Fund L.p. is the Director of Apogee Therapeutics Inc and owns about 2,941,176 shares of Apogee Therapeutics Inc (APGE) stock worth over $167 Million. Details can be seen in Fairmount Healthcare Fund L.p.'s Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Fairmount Healthcare Fund L.p. has not made any transactions after 2023-07-13 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Fairmount Healthcare Fund L.p.

To

Fairmount Healthcare Fund L.p. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Fairmount Healthcare Fund L.p. owns 3 companies in total, including Viridian Therapeutics Inc (VRDN) , Spyre Therapeutics Inc (SYRE) , and Apogee Therapeutics Inc (APGE) .

Click here to see the complete history of Fairmount Healthcare Fund L.p.’s form 4 insider trades.

Insider Ownership Summary of Fairmount Healthcare Fund L.p.

Ticker Comapny Transaction Date Type of Owner
VRDN Viridian Therapeutics Inc 2020-10-27 director & other: See Remarks
SYRE Spyre Therapeutics Inc 2023-06-22 director & 10 percent owner
APGE Apogee Therapeutics Inc 2023-07-13 director

Fairmount Healthcare Fund L.p. Latest Holdings Summary

Fairmount Healthcare Fund L.p. currently owns a total of 1 stock. Fairmount Healthcare Fund L.p. owns 2,941,176 shares of Apogee Therapeutics Inc (APGE) as of July 13, 2023, with a value of $167 Million.

Latest Holdings of Fairmount Healthcare Fund L.p.

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
APGE Apogee Therapeutics Inc 2023-07-13 2,941,176 56.67 166,661,738

Holding Weightings of Fairmount Healthcare Fund L.p.


Fairmount Healthcare Fund L.p. Form 4 Trading Tracker

According to the SEC Form 4 filings, Fairmount Healthcare Fund L.p. has made a total of 1 transactions in Apogee Therapeutics Inc (APGE) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Apogee Therapeutics Inc is the acquisition of 2,941,176 shares on July 13, 2023, which cost Fairmount Healthcare Fund L.p. around $50 Million.

Insider Trading History of Fairmount Healthcare Fund L.p.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Fairmount Healthcare Fund L.p. Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Fairmount Healthcare Fund L.p. Ownership Network

Ownership Network List of Fairmount Healthcare Fund L.p.

No Data

Ownership Network Relation of Fairmount Healthcare Fund L.p.

Insider Network Chart

Fairmount Healthcare Fund L.p. Owned Company Details

What does Viridian Therapeutics Inc do?

Who are the key executives at Viridian Therapeutics Inc?

Fairmount Healthcare Fund L.p. is the director & other: See Remarks of Viridian Therapeutics Inc. Other key executives at Viridian Therapeutics Inc include director & President and CEO Stephen F. Mahoney , Chief Operating Officer Thomas W. Beetham , and director & other: See Remarks Fairmount Healthcare Fund Ii Gp Llc .

Viridian Therapeutics Inc (VRDN) Insider Trades Summary

Over the past 18 months, Fairmount Healthcare Fund L.p. made no insider transaction in Viridian Therapeutics Inc (VRDN). Other recent insider transactions involving Viridian Therapeutics Inc (VRDN) include a net sale of 9,796 shares made by Lara Meisner , a net purchase of 1,600,000 shares made by Fairmount Healthcare Fund Ii Gp Llc , and a net purchase of 476,190 shares made by Fairmount Healthcare Fund Gp Llc .

In summary, during the past 3 months, insiders sold 0 shares of Viridian Therapeutics Inc (VRDN) in total and bought 1,626,400 shares, with a net purchase of 1,626,400 shares. During the past 18 months, 9,796 shares of Viridian Therapeutics Inc (VRDN) were sold and 2,102,590 shares were bought by its insiders, resulting in a net purchase of 2,092,794 shares.

Viridian Therapeutics Inc (VRDN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Viridian Therapeutics Inc Insider Transactions

No Available Data

Fairmount Healthcare Fund L.p. Mailing Address

Above is the net worth, insider trading, and ownership report for Fairmount Healthcare Fund L.p.. You might contact Fairmount Healthcare Fund L.p. via mailing address: 2001 Market Street, Suite 2500, Philadelphia Pa 19103.